A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Summary

The main purpose of this study is to compare LY900014 to insulin lispro (Humalog) in participants with type 1 diabetes who are using an insulin pump and have high blood sugar after eating. For each participant, the study will last about two to nine weeks.

Timeline

Start

2020-02-25

Primary completion

2020-08-10

Completion

2020-08-10

Publications

• Leohr J, Dellva MA, LaBell E, Coutant DE, Arrubla J, Plum-Morschel L, Zijlstra E, Fukuda T, Hardy T. Ultra rapid lispro (Lyumjev(R)) shortens time to recovery from hyperglycaemia compared to Humalog(R) in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Obes Metab. 2024 Jan;26(1):215-223. doi: 10.1111/dom.15307. Epub 2023 Oct 9.

Drugs

Indications